Neither source is universally "better," as both umbilical cord blood and bone marrow possess distinct clinical advantages and limitations depending on the medical condition being treated. Cord blood stem cells are exceptionally adaptable, do not require an exact human leukocyte antigen match, and can be collected non-invasively without discomfort. However, bone marrow yields a significantly higher total volume of stem cells, making it frequently preferred for treating heavier adult patients where larger cell doses are mandatory for successful engraftment.